Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank33
3Y CAGR-64.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-64.7%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 438.05 | -94.8% |
| 2023 | 8365.50 | +140.2% |
| 2022 | 3482.76 | -64.9% |
| 2021 | 9933.23 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 4674.67 | - |